SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181151-06-000004
Filing Date
2006-05-19
Accepted
2006-05-19 14:58:45
Documents
1
Period of Report
2006-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10470
  Complete submission text file 0001181151-06-000004.txt   12307
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address PHARMACEUTICAL PRODUCT DEVELOPMENT INC 3151 S 17TH ST WILMINGTON DE 28412 9102510081
BADDOUR LINDA (Reporting) CIK: 0001181151 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 06854914